Mirjam Teboe/LinkedIn
May 13, 2026, 16:06
Mirjam Teboe: APS Diagnosis Faces False Positive Challenges in Lupus Anticoagulant Testing
Mirjam Teboe, Head of Workforce Development for Global Infrastructure and Solutions at Roche, shared a post on LinkedIn:
“Antiphospholipid Syndrome (APS) diagnosis can be an ‘analytical minefield,’ with Lupus Anticoagulant testing seeing false positives as high as 23%.
Learn from pioneer Professor Vittorio Pengo as he reveals the ‘Golden Rule’ for blood draws and how to achieve laboratory precision in our latest Lab Leaders expert interview!.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 14, 2026, 01:59Samar Al Emadi: Anti-Annexin A5 Antibodies and Annexin A5 Resistance in Antiphospholipid Syndrome
-
May 14, 2026, 01:56Did You Know Your Follicle Count Doesn’t Stay the Same Throughout Your Cycle? – Fertility Plus
-
May 13, 2026, 16:24Shanza Ghaffar: Recurrent Pregnancy Loss Beyond Diagnosis and Treatment
-
May 13, 2026, 16:16Alejandro González: A Historic Moment for the PCOS Community
-
May 13, 2026, 16:15Antonio La Marca: Where There Is Research, There Is Better Care
-
May 13, 2026, 16:03The Link Between Lifestyle and Environmental Exposures and Endometriotic Phenotype – RBMO
-
May 13, 2026, 11:42Analysis of MED-12 Mutations in Uterine Leiomyomas of Nigerian Women – Fertility and Sterility
-
May 13, 2026, 11:33Anuja Dokras: SPIRE 2026 Brings Together the Global Fertility Community
-
May 13, 2026, 11:23Sean Lauber: Why Do Aneuploid Embryos Rarely Lead to Live Births?